OKT3 delays rejection crises after heart transplantation.
Weimar
W
W
Transplantation Working Group, University Hospital Rotterdam-Dijkzigt, The Netherlands.
Essed
C E
CE
Balk
A H
AH
Simoons
M L
ML
Hendriks
G F
GF
Wenting
G J
GJ
Mochtar
B
B
Bos
E
E
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use; D006084:Graft Rejection; D016027:Heart Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016853:Muromonab-CD3; D011183:Postoperative Complications / Q000517:prevention & control
D000911:Antibodies, Monoclonal; D003524:Cyclosporins; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3